Abstract A125: External Control Arms: a vital strategy to create high quality scientific evidence with patient centric trial design for pancreatic cancer trials in light of introduction of highly effective targeted therapies
AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development The evolution of targeted therapies in pancreatic ductal adenocarcinoma (PDAC) may pose challenges for future clinical research. Assigning patients to standard-of-care chemotherapies in randomized controlled trials (...